SISRAM MEDICAL LTD |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 3.54 HKD | +7.93% |
|
+13.46% | -32.70% |
| 03-21 | Sisram Medical’s Profit Down in Fiscal 2023 | MT |
| 03-20 | Sisram Medical Ltd Announces Ordinary Final Cash Dividend for the Year Ended December 31, 2023 | CI |
| Sales 2023 | 359M 2.81B 28.76B | Sales 2024 * | 394M 3.09B 31.58B | Capitalization | 212M 1.66B 16.95B |
|---|---|---|---|---|---|
| Net income 2023 | 31M 243M 2.48B | Net income 2024 * | 35M 274M 2.8B | EV / Sales 2023 | 0.88 x |
| Net cash position 2023 * | - 0 0 | Net cash position 2024 * | - 0 0 | EV / Sales 2024 * | 0.54 x |
| P/E ratio 2023 * |
-
| P/E ratio 2024 * |
-
| Employees | 1,080 |
| Yield 2023 |
3% | Yield 2024 * |
4.42% | Free-Float | 28.43% |
More Fundamentals
* Assessed data
More news
More press releases
| 1 day | +7.93% | ||
| 1 week | +13.46% | ||
| Current month | +0.28% | ||
| 1 month | -0.28% | ||
| 3 months | -22.54% | ||
| 6 months | -32.95% | ||
| Current year | -32.70% |
1 week
3.00
3.56
1 month
2.963.83
Current year
2.965.50
1 year
2.9612.02
3 years
2.9635.00
5 years
2.1135.00
10 years
2.1135.00
| Managers | Title | Age | Since |
|---|---|---|---|
Lior Moshe Dayan
CEO | Chief Executive Officer | 54 | 05/06/17 |
Nikol Lev
CTO | Chief Tech/Sci/R&D Officer | - | - |
Itay Meir
CTO | Chief Tech/Sci/R&D Officer | - | - |
| Members of the board | Title | Age | Since |
|---|---|---|---|
Heung Sang Fong
BRD | Director/Board Member | 64 | 31/12/16 |
Yi Fang Wu
BRD | Director/Board Member | 54 | 16/10/16 |
Lior Moshe Dayan
CEO | Chief Executive Officer | 54 | 05/06/17 |
| Name | Weight | AuM | 1st Jan change | Investor Rating |
|---|---|---|---|---|
| 0.00% | 7 M€ | +1.95% | - | |
| 0.00% | 10 M€ | -3.35% | - |
| Date | Price | Change | Volume |
|---|---|---|---|
| 26/04/24 | 3.54 | +7.93% | 1,493,200 |
| 25/04/24 | 3.28 | +1.23% | 684,400 |
| 24/04/24 | 3.24 | -0.31% | 613,600 |
| 23/04/24 | 3.25 | +3.17% | 529,200 |
| 22/04/24 | 3.15 | +0.96% | 440,000 |
Delayed Quote Hong Kong S.E., April 26, 2024 at 09:08 am
More quotes
Sisram Medical Ltd is an investment holding company principally engaged in the design, development, manufacture and distribution of energy cosmetic medicine and minimally invasive medical cosmetic treatment systems. The Company has a comprehensive medical cosmetic equipment portfolio, including medical beauty product line and life beauty product line, can be used for noninvasive medical cosmetic treatment, such as hair removal, rejuvenation, skin care, vascular treatment and pigmented lesions treatment, removal of tattoos, acne Treatment, fat reduction, body shaping and firming. The Company's medical cosmetic equipment can also be used for minimally invasive medical cosmetic treatment, such as private beauty treatment, laser liposuction, treatment of varicose veins and treatment of hyperhidrosis. The company sells its products in domestic and foreign markets.
Calendar
20/08/2024
- Q2 2024 Earnings Release (Projected)
Trading Rating
Investor Rating
ESG Refinitiv
Sell
Buy
Mean consensus
BUY
Number of Analysts
2
Last Close Price
0.4522
USD
Average target price
0.7795
USD
Spread / Average Target
+72.38%
Annual profits - Rate of surprise
| 1st Jan change | Capi. | |
|---|---|---|
| -32.70% | 212M | |
| +19.38% | 994M | |
| -35.85% | 74.33M |
- Stock Market
- Equities
- 1696 Stock
